What Is the Role of Glucagon in Peptide Product Composition?
Abstract: Glucagon, a 29-amino acid peptide hormone, plays a critical role in peptide product composition by counteracting insulin to regulate glucose homeostasis. In the rapidly expanding peptide therapeutics market (projected to exceed USD 50 billion by 2030), glucagon analogs are pivotal for diabetes and obesity management. Comparative analysis of leading brands (e.g., Novo Nordisk’s Gvoke vs. Xeris’s GVOKE PFS) reveals key differences in stability, formulation (liquid vs. lyophilized), and delivery devices. Technical advantages include rapid onset of action; disadvantages involve instability in solution and high production costs. Product parameters such as purity (>98%) and bioactivity are critical for regulatory compliance (FDA/EMA certifications). Selection criteria prioritize cold-chain logistics (2–8°C) and manufacturer GMP certifications. Industry trends highlight a shift toward dual-agonist peptides (e.g., glucagon/GIP/GLP-1) for enhanced efficacy.